- Synergy of Arbekacin-based Combinations Against Vancomycin Hetero-intermediate Staphylococcus aureus
-
Lee JY, Oh WS, Ko KS, Heo ST, Moon CS, Ki HK, Kiem S, Peck KR, Song JH
- KMID: 1781820
- J Korean Med Sci.
- 2006 Apr;21(2):188-192.
- doi: 10.3346/jkms.2006.21.2.188
This study was undertaken to evaluate the in vitro activities of arbekacin-based combination regimens against vancomycin hetero-intermediate Staphylococcus aureus (hetero-VISA). Combinations of arbekacin with vancomycin, rifampin, ampicillin-sulbactam, teicoplanin, or quinipristin-dalfopristin... -
- CITED
-
- Close
- SHARE
-
- Close
- Teicoplanin Dosing Strategy for Treatment of Staphylococcus aureus in Korean Patients with Neutropenic Fever
-
Ahn BJ, Yim DS, Lee DG, Kwon JC, Kim SH, Choi SM
- KMID: 1727994
- Yonsei Med J.
- 2011 Jul;52(4):616-623.
- doi: 10.3349/ymj.2011.52.4.616
PURPOSE: The present study was conducted to determine and compare the target attainment rate (TAR) between microorganism-nonspecific (Ctrough) and microorganism-specific (AUC24/MIC) targets over two weeks of teicoplanin administration according to... -
- CITED
-
- Close
- SHARE
-
- Close
